Jharkhand High Court Directs FIR in Alleged HIV-Contaminated Blood Transfusion to Minor Patients

Introduction

In a significant ruling aimed at upholding the statutory duty of police to register First Information Reports (FIRs) for cognizable offences, the Jharkhand High Court has ordered the immediate registration of an FIR concerning allegations of HIV-infected blood being transfused to minor thalassemia patients at the Blood Bank of Chaibasa Sadar Hospital in West Singhbhum district. The decision, delivered by a Single Judge Bench comprising Hon'ble Mr. Justice Gautam Kumar Choudhary on February 4, 2026, in the writ petition Deepika Hembram (through her natural guardian Anita Hembram) & Ors. v. State of Jharkhand & Ors. (W.P. (Cr) No. 50 of 2026), addresses a grave instance of potential medical negligence that allegedly endangered the lives of five minor children from marginalized communities. The petitioners, represented by advocate Mr. Md. Shadab Ansari, sought not only FIR registration but also the formation of a Special Investigation Team (SIT) under court supervision to probe the incident and assign criminal liability. The State, through Ms. Amrita Banerjee, argued that no formal complaint had been received. This order reinforces the legal obligation under criminal procedure to act swiftly on disclosures of cognizable offences, particularly in public health matters involving vulnerable populations, and sets the matter for further hearing on February 18, 2026.

The case highlights broader concerns over blood bank safety protocols and the accountability of healthcare institutions in India, especially in rural and underserved areas like West Singhbhum. By directing the petitioners' guardians to submit a written report for FIR registration without delay, the court has bridged a procedural gap that had left the victims without recourse, emphasizing the intersection of criminal law, public health regulations, and social justice.

Case Background

The origins of this writ petition trace back to October 2025, when five minor children suffering from thalassemia—a chronic blood disorder requiring regular transfusions—allegedly received HIV-contaminated blood at the Blood Bank of Chaibasa Sadar Hospital, a government-run facility in West Singhbhum, Jharkhand. The petitioners, including Deepika Hembram represented through her natural guardian Anita Hembram and four other minors through their guardians, belong to economically disadvantaged and marginalized sections of society, often tribal communities in the region. Thalassemia patients depend on safe blood supplies for survival, making the hospital's blood bank a critical lifeline. However, the alleged failure in screening procedures reportedly led to these children contracting HIV, a life-threatening virus that compromises their already fragile health.

The events leading to the legal dispute began when a written complaint was reportedly filed by one Dusru Kunkal with the Officer-in-Charge of Chaibasa Sadar Police Station, detailing the transfusion of infected blood and the subsequent HIV diagnoses. Despite this, no FIR was registered, prompting the guardians to approach the Jharkhand High Court via a criminal writ petition in early 2026. The petition, filed under Article 226 of the Constitution read with Section 482 of the Code of Criminal Procedure, 1973 (CrPC), sought multiple reliefs: directions to register an FIR, constitution of an SIT for a thorough, impartial, and time-bound investigation monitored by the court, and fixation of criminal liability on those responsible, including blood bank officials.

This is not an isolated incident in India, where lapses in blood bank operations have previously led to similar tragedies, underscoring systemic issues in healthcare infrastructure. The timeline reveals a pattern of delay: the transfusions occurred in October 2025, the initial complaint was lodged soon after, but by February 2026, no police action had been taken, compelling judicial intervention. The main legal questions at hand include whether the alleged transfusion of infected blood constitutes a cognizable offence under relevant laws, the police's mandatory duty to register an FIR upon disclosure of such an offence, and the court's power to direct investigation in cases involving public health and vulnerable groups. The petition also raises questions about the classification of HIV-infected blood as a "spurious drug" under the Drugs and Cosmetics Act, 1940, potentially invoking penal provisions for its mishandling.

Arguments Presented

The petitioners' counsel, Mr. Md. Shadab Ansari, presented a compelling case rooted in both factual allegations and legal imperatives. He argued that the acts and omissions of the blood bank personnel—specifically, the failure to properly screen donated blood for HIV—directly imperiled the lives of the five minor children, who tested positive for the virus post-transfusion. Emphasizing the petitioners' socioeconomic vulnerability, Ansari highlighted that these children from poor, marginalized families rely entirely on public healthcare facilities like Chaibasa Sadar Hospital. He contended that a complaint had already been submitted to the local police station by Dusru Kunkal, yet the authorities failed to register an FIR, violating the petitioners' right to justice. Legally, he invoked Section 154 CrPC, which mandates FIR registration for cognizable offences, and linked the incident to Section 3(b) of the Drugs and Cosmetics Act, 1940, defining infected blood as adulterated or spurious. Furthermore, under Section 36AC of the same Act, the use or supply of such spurious drugs is a cognizable and non-bailable offence, punishable with imprisonment and fines. The counsel urged the court to direct FIR registration and constitute an SIT to ensure an unbiased probe, preventing any cover-up by state authorities and holding accountable those responsible for the negligence.

In response, the State, represented by Ms. Amrita Banerjee as Additional Counsel to the Government Pleader, maintained that no formal complaint had been received from the petitioners or their guardians at the Chaibasa Sadar Police Station. She submitted, based on instructions from state officials, that without a proper written report from the affected parties, no case could be registered, as police procedure requires direct input from victims or informants. The State argued that the annexed copy of the written report in the petition lacked a date, rendering it informal and insufficient for initiating proceedings. Banerjee implicitly defended the hospital's operations, suggesting that the absence of a verified complaint indicated no substantiated cognizable offence had been formally disclosed. She resisted the prayer for an SIT, implying that standard police investigation mechanisms should suffice once a valid complaint is filed, without necessitating court-monitored intervention at this stage. Key factual points raised by the State included the lack of direct evidence linking the transfusions to HIV infections beyond the petitioners' claims, and the procedural safeguard that FIRs cannot be lodged based on undated or third-party reports alone.

Both sides clashed on the urgency and gravity: the petitioners portrayed the incident as a blatant criminal negligence endangering lives, while the State focused on procedural formalities, highlighting a tension between access to justice for the vulnerable and administrative rigor in criminal reporting.

Legal Analysis

The Jharkhand High Court's reasoning centers on the unassailable legal principle that police are statutorily bound to register an FIR whenever a complaint discloses a cognizable offence, a cornerstone of criminal jurisprudence under Section 154 CrPC. Justice Gautam Kumar Choudhary meticulously applied this to the facts, classifying the alleged transfusion of HIV-infected blood as falling within the ambit of the Drugs and Cosmetics Act, 1940. Specifically, the court noted that "infected blood will come in view of the definition under Section 3(b)" of the Act, which deems blood that does not conform to prescribed standards as adulterated or spurious. The manufacture, sale, or distribution of such spurious drugs is criminalized under Section 27, and importantly, Section 36AC designates these offences as cognizable, empowering police to act without warrant and mandating FIR registration.

While the judgment does not cite specific precedents, it implicitly draws from landmark Supreme Court rulings like Lalita Kumari v. Govt. of Uttar Pradesh (2014), which established that registration of FIR is mandatory for cognizable offences and cannot be withheld on preliminary inquiries unless exceptional circumstances exist—none of which apply here, given the clear disclosure of a serious public health violation. The court's analysis distinguishes between mere medical errors and criminal negligence: the latter, involving systemic lapses in blood screening that endanger lives, attracts penal consequences under the Drugs Act, akin to cases involving counterfeit medicines. Justice Choudhary also considered the social context, noting the petitioners' marginalized status, which aligns with constitutional imperatives under Article 21 (right to life and health) and Article 39A (equal justice), ensuring that procedural delays do not perpetuate injustice against the underprivileged.

The ruling clarifies that the absence of a dated complaint copy does not bar action; instead, it empowers the court to direct the informants to formalize their report, thereby streamlining access to justice without condoning police inaction. No other statutes like the Epidemic Diseases Act, 1897, or IPC provisions for negligence (e.g., Section 304A) were directly invoked, but the focus remains on the cognizable nature of the offence under the Drugs Act, distinguishing it from non-cognizable matters requiring magisterial orders. This approach underscores the court's role in enforcing accountability in healthcare, particularly where state-run facilities serve as the sole recourse for rural populations, potentially influencing how similar cases of blood bank malpractices are handled nationwide.

Key Observations

The judgment is replete with pivotal observations that encapsulate the court's commitment to procedural justice and public health safeguards. Key excerpts include:

• “There cannot be any cavil with the legal proposition that the police is under the statutory duty to lodge FIR when the complaint discloses a cognizable offence.” This underscores the non-discretionary nature of FIR registration, rejecting any pretext for delay.

• “Infected blood will come in view of the definition under Section 3(b) of the Drugs and Cosmetics Act, 1940. The use of spurious drugs is a cognizable offence under Section 36AC of the Drugs and Cosmetics Act, 1940.” Here, the court directly ties the medical lapse to criminal liability, expanding the Act's application to blood products.

• “The petitioners are from poor and marginalized section of society and despite the complaint, FIR has not been lodged.” This highlights equity considerations, ensuring that socioeconomic barriers do not impede legal remedies.

• “Under the circumstance, any of the petitioners through their guardian to lodge written report before concerned police station, which will be registered without any delay and a copy of the same will be given to the informant.” This directive practically operationalizes the FIR mandate, bridging the gap between allegation and investigation.

These observations, drawn verbatim from the order, emphasize the interplay of law, vulnerability, and accountability, serving as guiding principles for similar petitions.

Court's Decision

The Jharkhand High Court unequivocally directed the registration of an FIR by ordering that "any of the petitioners through their guardian [shall] lodge written report before concerned police station, which will be registered without any delay." The Officer-in-Charge of the Chaibasa Sadar Police Station was further instructed to provide a copy of the FIR to the informant and to file the written report before the court via a counter-affidavit. While the prayer for constituting an SIT was not immediately granted, the court's monitoring through subsequent hearings implies potential oversight if needed. The matter is listed for next hearing on February 18, 2026, allowing time for compliance and preliminary investigation updates.

This decision has profound practical effects: it compels immediate police action, potentially leading to arrests and charges under the Drugs and Cosmetics Act, thereby holding blood bank officials accountable for screening failures. For the affected minors, it opens avenues for thorough probes, compensation claims, and medical support, mitigating the irreversible harm from HIV infection. Broader implications include strengthened enforcement of blood safety standards across Indian hospitals, particularly in government facilities serving low-income groups. Future cases involving medical negligence—such as faulty drug distribution or vaccine mishandling—may cite this ruling to expedite FIRs, reducing impunity in public health sectors. By prioritizing marginalized voices, the order reinforces judicial activism in ensuring Article 21 protections, potentially inspiring similar interventions in other high courts and influencing policy reforms like mandatory audits for blood banks. Ultimately, it serves as a deterrent against negligence, promoting safer healthcare delivery and equitable justice.